ConductScience.org, home

Paper39149209

Efficacy of Limosilactobacillus fermentum in the management of vulvovaginal candidiasis: comparative analysis with topical miconazole in a single-blind randomized clinical trial.

Pane M and 1 other. Front Microbiol, 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Efficacy of Limosilactobacillus fermentum in the management of vulvovaginal candidiasis: comparative analysis with topical miconazole in a single-blind randomized clinical trial. Papers, record 39149209. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39149209

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy of Limosilactobacillus fermentum in the management of vulvovaginal candidiasis: comparative analysis with topical miconazole in a single-blind randomized clinical trial.
PubMed
Journal
Front Microbiol
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.69, provisional
iCite
Revised in PubMed
2024-08-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pane MMarco
2Chisari EEmanuele

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129168557Probiotics for vulvovaginal candidiasis in non-pregnant women.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/29168557PubMed
225291115Can Lactobacillus fermentum LF10 and Lactobacillus acidophilus LA02 in a slow-release vaginal product be useful for prevention of recurrent vulvovaginal candidiasis?: A clinical study.J Clin Gastroenterol2014https://conductscience.org/library/papers/25291115PubMed
335352028Tackling the emerging threat of antifungal resistance to human health.Nat Rev Microbiol2022https://conductscience.org/library/papers/35352028PubMed
438647290Controlling Candida: immune regulation of commensal fungi in the gut.Infect Immun2024https://conductscience.org/library/papers/38647290PubMed
537147720Quality of life in women with chronic recurrent vulvovaginal candidosis: A sub-analysis of the prospective multicentre phase IIb/III Prof-001 study.Mycoses2023https://conductscience.org/library/papers/37147720PubMed
627741167In Vitro Activity of Lactobacillus fermentum LF5 Against Different Candida Species and Gardnerella vaginalis: A New Perspective to Approach Mixed Vaginal Infections?J Clin Gastroenterol2016https://conductscience.org/library/papers/27741167PubMed
712530485Can the diagnosis of recurrent vulvovaginal candidosis be improved by use of vaginal lavage samples and cultures on chromogenic agar?Infect Dis Obstet Gynecol2002https://conductscience.org/library/papers/12530485PubMed
827741168The In Vitro Effectiveness of Lactobacillus fermentum Against Different Candida Species Compared With Broadly Used Azoles.J Clin Gastroenterol2016https://conductscience.org/library/papers/27741168PubMed
921327023Safety assessment of probiotics for human use.Gut Microbes2010https://conductscience.org/library/papers/21327023PubMed
1037189681Antifungal Drug Resistance: An Emergent Health Threat.Biomedicines2023https://conductscience.org/library/papers/37189681PubMed
1133918150Vaginal Probiotics for Reproductive Health and Related Dysbiosis: Systematic Review and Meta-Analysis.J Clin Med2021https://conductscience.org/library/papers/33918150PubMed
1220725094An insight into the antifungal pipeline: selected new molecules and beyond.Nat Rev Drug Discov2010https://conductscience.org/library/papers/20725094PubMed
133529970Therapy of candidal vaginitis: the effect of eliminating intestinal Candida. Nystatin Multicenter Study Group.Am J Obstet Gynecol1986https://conductscience.org/library/papers/3529970PubMed
1431270690Influence of recurrent vulvovaginal candidiasis on quality of life issues.Arch Gynecol Obstet2019https://conductscience.org/library/papers/31270690PubMed
1536816582Vulvovaginal candidiasis and vaginal microflora interaction: Microflora changes and probiotic therapy.Front Cell Infect Microbiol2023https://conductscience.org/library/papers/36816582PubMed
1622955364Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.J Clin Gastroenterol2012https://conductscience.org/library/papers/22955364PubMed
1735005777Treatment for recurrent vulvovaginal candidiasis (thrush).Cochrane Database Syst Rev2022https://conductscience.org/library/papers/35005777PubMed
1814709186Candida transmission and sexual behaviors as risks for a repeat episode of Candida vulvovaginitis.J Womens Health (Larchmt)2003https://conductscience.org/library/papers/14709186PubMed
1917560449Vulvovaginal candidosis.Lancet2007https://conductscience.org/library/papers/17560449PubMed
2016790461Probiotics for prevention of recurrent vulvovaginal candidiasis: a review.J Antimicrob Chemother2006https://conductscience.org/library/papers/16790461PubMed

See all 21 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
42588524Intravaginal Formulation Strategies for Vaginal Disorders: Optimizing Phytochemical and Biological Preparations-A Review.Molecules2026https://conductscience.org/library/papers/42588524

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39149209

GET https://conductscience.org/api/papers/v1/39149209/references?page=2